Global Live Attenuated Polio Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 93

Published Date: 26 Aug 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Live Attenuated Polio Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

The Global Info Research report includes an overview of the development of the Live Attenuated Polio Vaccine industry chain, the market status of Hospital (Live Attenuated Vaccine, Inactivated Vaccine), Clinic (Live Attenuated Vaccine, Inactivated Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Live Attenuated Polio Vaccine.

Regionally, the report analyzes the Live Attenuated Polio Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Live Attenuated Polio Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Live Attenuated Polio Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Live Attenuated Polio Vaccine industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Live Attenuated Vaccine, Inactivated Vaccine).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Live Attenuated Polio Vaccine market.

Regional Analysis: The report involves examining the Live Attenuated Polio Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Live Attenuated Polio Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Live Attenuated Polio Vaccine:
Company Analysis: Report covers individual Live Attenuated Polio Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Live Attenuated Polio Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).

Technology Analysis: Report covers specific technologies relevant to Live Attenuated Polio Vaccine. It assesses the current state, advancements, and potential future developments in Live Attenuated Polio Vaccine areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Live Attenuated Polio Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Live Attenuated Polio Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Live Attenuated Vaccine
Inactivated Vaccine

Market segment by Application
Hospital
Clinic
Health Center
Others

Major players covered
Sanofi Pasteur
GlaxoSmithKline Bio
Bilthoven Bio
Bharat Biotech
Sinovac Biotech

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Live Attenuated Polio Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Live Attenuated Polio Vaccine, with price, sales, revenue and global market share of Live Attenuated Polio Vaccine from 2018 to 2023.
Chapter 3, the Live Attenuated Polio Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Live Attenuated Polio Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Live Attenuated Polio Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Live Attenuated Polio Vaccine.
Chapter 14 and 15, to describe Live Attenuated Polio Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Live Attenuated Polio Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Live Attenuated Polio Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Live Attenuated Vaccine
        1.3.3 Inactivated Vaccine
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Live Attenuated Polio Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital
        1.4.3 Clinic
        1.4.4 Health Center
        1.4.5 Others
    1.5 Global Live Attenuated Polio Vaccine Market Size & Forecast
        1.5.1 Global Live Attenuated Polio Vaccine Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Live Attenuated Polio Vaccine Sales Quantity (2018-2029)
        1.5.3 Global Live Attenuated Polio Vaccine Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Sanofi Pasteur
        2.1.1 Sanofi Pasteur Details
        2.1.2 Sanofi Pasteur Major Business
        2.1.3 Sanofi Pasteur Live Attenuated Polio Vaccine Product and Services
        2.1.4 Sanofi Pasteur Live Attenuated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Sanofi Pasteur Recent Developments/Updates
    2.2 GlaxoSmithKline Bio
        2.2.1 GlaxoSmithKline Bio Details
        2.2.2 GlaxoSmithKline Bio Major Business
        2.2.3 GlaxoSmithKline Bio Live Attenuated Polio Vaccine Product and Services
        2.2.4 GlaxoSmithKline Bio Live Attenuated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 GlaxoSmithKline Bio Recent Developments/Updates
    2.3 Bilthoven Bio
        2.3.1 Bilthoven Bio Details
        2.3.2 Bilthoven Bio Major Business
        2.3.3 Bilthoven Bio Live Attenuated Polio Vaccine Product and Services
        2.3.4 Bilthoven Bio Live Attenuated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Bilthoven Bio Recent Developments/Updates
    2.4 Bharat Biotech
        2.4.1 Bharat Biotech Details
        2.4.2 Bharat Biotech Major Business
        2.4.3 Bharat Biotech Live Attenuated Polio Vaccine Product and Services
        2.4.4 Bharat Biotech Live Attenuated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Bharat Biotech Recent Developments/Updates
    2.5 Sinovac Biotech
        2.5.1 Sinovac Biotech Details
        2.5.2 Sinovac Biotech Major Business
        2.5.3 Sinovac Biotech Live Attenuated Polio Vaccine Product and Services
        2.5.4 Sinovac Biotech Live Attenuated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Sinovac Biotech Recent Developments/Updates

3 Competitive Environment: Live Attenuated Polio Vaccine by Manufacturer
    3.1 Global Live Attenuated Polio Vaccine Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Live Attenuated Polio Vaccine Revenue by Manufacturer (2018-2023)
    3.3 Global Live Attenuated Polio Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Live Attenuated Polio Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Live Attenuated Polio Vaccine Manufacturer Market Share in 2022
        3.4.2 Top 6 Live Attenuated Polio Vaccine Manufacturer Market Share in 2022
    3.5 Live Attenuated Polio Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Live Attenuated Polio Vaccine Market: Region Footprint
        3.5.2 Live Attenuated Polio Vaccine Market: Company Product Type Footprint
        3.5.3 Live Attenuated Polio Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Live Attenuated Polio Vaccine Market Size by Region
        4.1.1 Global Live Attenuated Polio Vaccine Sales Quantity by Region (2018-2029)
        4.1.2 Global Live Attenuated Polio Vaccine Consumption Value by Region (2018-2029)
        4.1.3 Global Live Attenuated Polio Vaccine Average Price by Region (2018-2029)
    4.2 North America Live Attenuated Polio Vaccine Consumption Value (2018-2029)
    4.3 Europe Live Attenuated Polio Vaccine Consumption Value (2018-2029)
    4.4 Asia-Pacific Live Attenuated Polio Vaccine Consumption Value (2018-2029)
    4.5 South America Live Attenuated Polio Vaccine Consumption Value (2018-2029)
    4.6 Middle East and Africa Live Attenuated Polio Vaccine Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Live Attenuated Polio Vaccine Sales Quantity by Type (2018-2029)
    5.2 Global Live Attenuated Polio Vaccine Consumption Value by Type (2018-2029)
    5.3 Global Live Attenuated Polio Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Live Attenuated Polio Vaccine Sales Quantity by Application (2018-2029)
    6.2 Global Live Attenuated Polio Vaccine Consumption Value by Application (2018-2029)
    6.3 Global Live Attenuated Polio Vaccine Average Price by Application (2018-2029)

7 North America
    7.1 North America Live Attenuated Polio Vaccine Sales Quantity by Type (2018-2029)
    7.2 North America Live Attenuated Polio Vaccine Sales Quantity by Application (2018-2029)
    7.3 North America Live Attenuated Polio Vaccine Market Size by Country
        7.3.1 North America Live Attenuated Polio Vaccine Sales Quantity by Country (2018-2029)
        7.3.2 North America Live Attenuated Polio Vaccine Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Live Attenuated Polio Vaccine Sales Quantity by Type (2018-2029)
    8.2 Europe Live Attenuated Polio Vaccine Sales Quantity by Application (2018-2029)
    8.3 Europe Live Attenuated Polio Vaccine Market Size by Country
        8.3.1 Europe Live Attenuated Polio Vaccine Sales Quantity by Country (2018-2029)
        8.3.2 Europe Live Attenuated Polio Vaccine Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Live Attenuated Polio Vaccine Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Live Attenuated Polio Vaccine Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Live Attenuated Polio Vaccine Market Size by Region
        9.3.1 Asia-Pacific Live Attenuated Polio Vaccine Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Live Attenuated Polio Vaccine Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Live Attenuated Polio Vaccine Sales Quantity by Type (2018-2029)
    10.2 South America Live Attenuated Polio Vaccine Sales Quantity by Application (2018-2029)
    10.3 South America Live Attenuated Polio Vaccine Market Size by Country
        10.3.1 South America Live Attenuated Polio Vaccine Sales Quantity by Country (2018-2029)
        10.3.2 South America Live Attenuated Polio Vaccine Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Live Attenuated Polio Vaccine Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Live Attenuated Polio Vaccine Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Live Attenuated Polio Vaccine Market Size by Country
        11.3.1 Middle East & Africa Live Attenuated Polio Vaccine Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Live Attenuated Polio Vaccine Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Live Attenuated Polio Vaccine Market Drivers
    12.2 Live Attenuated Polio Vaccine Market Restraints
    12.3 Live Attenuated Polio Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Live Attenuated Polio Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Live Attenuated Polio Vaccine
    13.3 Live Attenuated Polio Vaccine Production Process
    13.4 Live Attenuated Polio Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Live Attenuated Polio Vaccine Typical Distributors
    14.3 Live Attenuated Polio Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Live Attenuated Polio Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Live Attenuated Polio Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
    Table 4. Sanofi Pasteur Major Business
    Table 5. Sanofi Pasteur Live Attenuated Polio Vaccine Product and Services
    Table 6. Sanofi Pasteur Live Attenuated Polio Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Sanofi Pasteur Recent Developments/Updates
    Table 8. GlaxoSmithKline Bio Basic Information, Manufacturing Base and Competitors
    Table 9. GlaxoSmithKline Bio Major Business
    Table 10. GlaxoSmithKline Bio Live Attenuated Polio Vaccine Product and Services
    Table 11. GlaxoSmithKline Bio Live Attenuated Polio Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. GlaxoSmithKline Bio Recent Developments/Updates
    Table 13. Bilthoven Bio Basic Information, Manufacturing Base and Competitors
    Table 14. Bilthoven Bio Major Business
    Table 15. Bilthoven Bio Live Attenuated Polio Vaccine Product and Services
    Table 16. Bilthoven Bio Live Attenuated Polio Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Bilthoven Bio Recent Developments/Updates
    Table 18. Bharat Biotech Basic Information, Manufacturing Base and Competitors
    Table 19. Bharat Biotech Major Business
    Table 20. Bharat Biotech Live Attenuated Polio Vaccine Product and Services
    Table 21. Bharat Biotech Live Attenuated Polio Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Bharat Biotech Recent Developments/Updates
    Table 23. Sinovac Biotech Basic Information, Manufacturing Base and Competitors
    Table 24. Sinovac Biotech Major Business
    Table 25. Sinovac Biotech Live Attenuated Polio Vaccine Product and Services
    Table 26. Sinovac Biotech Live Attenuated Polio Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Sinovac Biotech Recent Developments/Updates
    Table 28. Global Live Attenuated Polio Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 29. Global Live Attenuated Polio Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 30. Global Live Attenuated Polio Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 31. Market Position of Manufacturers in Live Attenuated Polio Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 32. Head Office and Live Attenuated Polio Vaccine Production Site of Key Manufacturer
    Table 33. Live Attenuated Polio Vaccine Market: Company Product Type Footprint
    Table 34. Live Attenuated Polio Vaccine Market: Company Product Application Footprint
    Table 35. Live Attenuated Polio Vaccine New Market Entrants and Barriers to Market Entry
    Table 36. Live Attenuated Polio Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 37. Global Live Attenuated Polio Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 38. Global Live Attenuated Polio Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 39. Global Live Attenuated Polio Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 40. Global Live Attenuated Polio Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 41. Global Live Attenuated Polio Vaccine Average Price by Region (2018-2023) & (US$/Unit)
    Table 42. Global Live Attenuated Polio Vaccine Average Price by Region (2024-2029) & (US$/Unit)
    Table 43. Global Live Attenuated Polio Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 44. Global Live Attenuated Polio Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 45. Global Live Attenuated Polio Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 46. Global Live Attenuated Polio Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 47. Global Live Attenuated Polio Vaccine Average Price by Type (2018-2023) & (US$/Unit)
    Table 48. Global Live Attenuated Polio Vaccine Average Price by Type (2024-2029) & (US$/Unit)
    Table 49. Global Live Attenuated Polio Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 50. Global Live Attenuated Polio Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 51. Global Live Attenuated Polio Vaccine Consumption Value by Application (2018-2023) & (USD Million)
    Table 52. Global Live Attenuated Polio Vaccine Consumption Value by Application (2024-2029) & (USD Million)
    Table 53. Global Live Attenuated Polio Vaccine Average Price by Application (2018-2023) & (US$/Unit)
    Table 54. Global Live Attenuated Polio Vaccine Average Price by Application (2024-2029) & (US$/Unit)
    Table 55. North America Live Attenuated Polio Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 56. North America Live Attenuated Polio Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 57. North America Live Attenuated Polio Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 58. North America Live Attenuated Polio Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 59. North America Live Attenuated Polio Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 60. North America Live Attenuated Polio Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 61. North America Live Attenuated Polio Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 62. North America Live Attenuated Polio Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 63. Europe Live Attenuated Polio Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 64. Europe Live Attenuated Polio Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 65. Europe Live Attenuated Polio Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 66. Europe Live Attenuated Polio Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 67. Europe Live Attenuated Polio Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 68. Europe Live Attenuated Polio Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 69. Europe Live Attenuated Polio Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 70. Europe Live Attenuated Polio Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 71. Asia-Pacific Live Attenuated Polio Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 72. Asia-Pacific Live Attenuated Polio Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 73. Asia-Pacific Live Attenuated Polio Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 74. Asia-Pacific Live Attenuated Polio Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 75. Asia-Pacific Live Attenuated Polio Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 76. Asia-Pacific Live Attenuated Polio Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 77. Asia-Pacific Live Attenuated Polio Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 78. Asia-Pacific Live Attenuated Polio Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 79. South America Live Attenuated Polio Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 80. South America Live Attenuated Polio Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 81. South America Live Attenuated Polio Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 82. South America Live Attenuated Polio Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 83. South America Live Attenuated Polio Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 84. South America Live Attenuated Polio Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 85. South America Live Attenuated Polio Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 86. South America Live Attenuated Polio Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 87. Middle East & Africa Live Attenuated Polio Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 88. Middle East & Africa Live Attenuated Polio Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 89. Middle East & Africa Live Attenuated Polio Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 90. Middle East & Africa Live Attenuated Polio Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 91. Middle East & Africa Live Attenuated Polio Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 92. Middle East & Africa Live Attenuated Polio Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 93. Middle East & Africa Live Attenuated Polio Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 94. Middle East & Africa Live Attenuated Polio Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 95. Live Attenuated Polio Vaccine Raw Material
    Table 96. Key Manufacturers of Live Attenuated Polio Vaccine Raw Materials
    Table 97. Live Attenuated Polio Vaccine Typical Distributors
    Table 98. Live Attenuated Polio Vaccine Typical Customers
List of Figures
    Figure 1. Live Attenuated Polio Vaccine Picture
    Figure 2. Global Live Attenuated Polio Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Live Attenuated Polio Vaccine Consumption Value Market Share by Type in 2022
    Figure 4. Live Attenuated Vaccine Examples
    Figure 5. Inactivated Vaccine Examples
    Figure 6. Global Live Attenuated Polio Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Live Attenuated Polio Vaccine Consumption Value Market Share by Application in 2022
    Figure 8. Hospital Examples
    Figure 9. Clinic Examples
    Figure 10. Health Center Examples
    Figure 11. Others Examples
    Figure 12. Global Live Attenuated Polio Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Live Attenuated Polio Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Live Attenuated Polio Vaccine Sales Quantity (2018-2029) & (K Units)
    Figure 15. Global Live Attenuated Polio Vaccine Average Price (2018-2029) & (US$/Unit)
    Figure 16. Global Live Attenuated Polio Vaccine Sales Quantity Market Share by Manufacturer in 2022
    Figure 17. Global Live Attenuated Polio Vaccine Consumption Value Market Share by Manufacturer in 2022
    Figure 18. Producer Shipments of Live Attenuated Polio Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 19. Top 3 Live Attenuated Polio Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Top 6 Live Attenuated Polio Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Global Live Attenuated Polio Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 22. Global Live Attenuated Polio Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 23. North America Live Attenuated Polio Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 24. Europe Live Attenuated Polio Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 25. Asia-Pacific Live Attenuated Polio Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 26. South America Live Attenuated Polio Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 27. Middle East & Africa Live Attenuated Polio Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 28. Global Live Attenuated Polio Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 29. Global Live Attenuated Polio Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 30. Global Live Attenuated Polio Vaccine Average Price by Type (2018-2029) & (US$/Unit)
    Figure 31. Global Live Attenuated Polio Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 32. Global Live Attenuated Polio Vaccine Consumption Value Market Share by Application (2018-2029)
    Figure 33. Global Live Attenuated Polio Vaccine Average Price by Application (2018-2029) & (US$/Unit)
    Figure 34. North America Live Attenuated Polio Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 35. North America Live Attenuated Polio Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 36. North America Live Attenuated Polio Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 37. North America Live Attenuated Polio Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 38. United States Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Canada Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Mexico Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Europe Live Attenuated Polio Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 42. Europe Live Attenuated Polio Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 43. Europe Live Attenuated Polio Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 44. Europe Live Attenuated Polio Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 45. Germany Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. France Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. United Kingdom Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Russia Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Italy Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Asia-Pacific Live Attenuated Polio Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 51. Asia-Pacific Live Attenuated Polio Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 52. Asia-Pacific Live Attenuated Polio Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 53. Asia-Pacific Live Attenuated Polio Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 54. China Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Japan Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Korea Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. India Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Southeast Asia Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Australia Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. South America Live Attenuated Polio Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 61. South America Live Attenuated Polio Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 62. South America Live Attenuated Polio Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 63. South America Live Attenuated Polio Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 64. Brazil Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Argentina Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Middle East & Africa Live Attenuated Polio Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 67. Middle East & Africa Live Attenuated Polio Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 68. Middle East & Africa Live Attenuated Polio Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 69. Middle East & Africa Live Attenuated Polio Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 70. Turkey Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Egypt Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Saudi Arabia Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. South Africa Live Attenuated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. Live Attenuated Polio Vaccine Market Drivers
    Figure 75. Live Attenuated Polio Vaccine Market Restraints
    Figure 76. Live Attenuated Polio Vaccine Market Trends
    Figure 77. Porters Five Forces Analysis
    Figure 78. Manufacturing Cost Structure Analysis of Live Attenuated Polio Vaccine in 2022
    Figure 79. Manufacturing Process Analysis of Live Attenuated Polio Vaccine
    Figure 80. Live Attenuated Polio Vaccine Industrial Chain
    Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 82. Direct Channel Pros & Cons
    Figure 83. Indirect Channel Pros & Cons
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi Pasteur
GlaxoSmithKline Bio
Bilthoven Bio
Bharat Biotech
Sinovac Biotech

Related Reports

Global Live Attenuated Polio Vaccine Supply, Demand and Key Producers, 2023-2029

Global Live Attenuated Polio Vaccine Supply, Demand and Key Producers, 2023-2029

date 26 Aug 2023

date Pharma & Healthcare

The global Live Attenuated Polio Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Live Attenuated Polio Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Live Attenuated Polio Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 07 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Live Attenuated Polio Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Live Attenuated Polio Vaccine Supply, Demand and Key Producers, 2024-2030

Global Live Attenuated Polio Vaccine Supply, Demand and Key Producers, 2024-2030

date 11 Feb 2024

date Pharma & Healthcare

The global Live Attenuated Polio Vaccine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Live Attenuated Polio Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>